Frailty Assessment in Older Adults
Use the Clinical Frailty Scale (CFS) for rapid bedside assessment in most clinical settings, or employ a Frailty Index with at least 30 deficits for comprehensive evaluation when time permits. 1
Primary Assessment Tools
Clinical Frailty Scale (CFS)
- The CFS is a 9-point judgment-based tool recommended by the American Geriatrics Society for rapid bedside assessment in most clinical settings. 1
- This tool provides fast, validated risk stratification and consistently classifies patients at increased risk of death while reducing the explanatory power of age alone. 1, 2
- In trauma settings, CFS scores of 6-7 independently predict adverse discharge disposition and increased 30-day mortality even with lower injury severity. 1
Frailty Index (Deficit Accumulation Approach)
- Calculate the Frailty Index as the fraction of deficits present divided by total deficits assessed, requiring a minimum of 30 age-related items for validity. 1, 2
- The specific deficits counted matter less than the total number assessed, provided ≥30 items are included. 1
- Express the degree of frailty as a continuous score (e.g., 0.35 indicates 35% of assessed deficits are present). 1
- Each 0.1 increment in the frailty index represents a 10% increase in accumulated deficits and corresponds to measurably increased hazard ratios for both cardiovascular and non-cardiovascular mortality. 1
- The Frailty Index can incorporate any combination of symptoms, signs, laboratory values, or functional measures. 1
Fried Frailty Phenotype
- Score patients on 5 physical criteria: low grip strength, slow walking speed, unintentional weight loss, exhaustion, and reduced physical activity. 1, 2
- Frailty is diagnosed when three or more of these five features are present. 2
Setting-Specific Assessment Approaches
Surgical and Trauma Settings
- Apply the Trauma-Specific Frailty Index (TSFI) for geriatric trauma patients—this 15-component modified scale predicts in-hospital complications and adverse discharge. 1
- The modified Frailty Index (mFI-5 or mFI-11) can be extracted from NSQIP database variables for surgical risk assessment. 1
Oncology Settings
- The American Society of Clinical Oncology recommends geriatric assessment for patients ≥65 years receiving chemotherapy to identify vulnerabilities. 3, 4
- A geriatric assessment must include sufficient domains: physical and cognitive function, emotional health, comorbid conditions, polypharmacy, nutrition, and social support. 3
- Use the Practical Geriatric Assessment (PGA) as the most concise, evidence-based version that aligns with available data and can be integrated into variably resourced clinical settings. 3
Ambulatory and Community Settings
- Implement routine frailty screening using standardized tools in all ambulatory patients with chronic conditions like cirrhosis. 1
- Use simple, validated frailty screening instruments rather than complex assessments. 4
- Artificial intelligence-based screening from electronic medical records is an emerging technology that can identify undiagnosed frailty. 3, 4
Cognitive Impairment and Dementia
- For older adults with cognitive impairment due to dementia, expert consensus recommends using brief, straightforward tools accessible to various clinicians. 2
Documentation Requirements
Chart the following elements for every frailty assessment: 1
- Tool used (CFS, Frailty Index, Fried Phenotype, etc.)
- Numeric score
- Frailty category (not-frail, pre-frail, or frail)
- Date of assessment
- Specific deficits identified
Monitoring and Reassessment
- Repeat assessments at follow-up intervals to track trajectory, as frailty states are dynamic and bidirectional. 1
- Frailty status fluctuates substantially, and changes in frailty are more predictive of mortality than current frailty status alone. 4
- After age 65, frailty develops at approximately twice the rate of younger individuals, with 12-24% of older adults demonstrating severe frailty. 1
Critical Pitfalls to Avoid
- Do not use modified frailty indices with <30 items when attempting the deficit accumulation approach—these have been criticized as too brief and may underestimate frailty. 1, 2
- Do not rely on clinical judgment alone to assess frailty, as it has not proven reliable in assessing frailty. 3
- Recognize that frailty is potentially reversible through interventions targeting physical activity, nutrition, and deficit accumulation. 1
Emerging Assessment Technologies
- Automated frailty indices developed using artificial intelligence and machine learning can case-find older adults with undiagnosed frailty from electronic medical records. 3, 4
- Biomarkers including skin autofluorescence and salivary α-amylase are newly identified markers, though more rigorous research is needed for omic-based biomarkers. 3
- Telephone-based frailty assessment has emerged as a practical option, particularly relevant during periods requiring remote consultation. 3
Clinical Implications of Assessment
- Both CFS and Frailty Index consistently classify patients at increased risk of death and reduce the explanatory power of age alone. 1, 2
- The degree of frailty fundamentally alters treatment decision-making by identifying patients who respond differently to standard therapies. 1
- Frailty assessment improves prognostication of toxicity outcomes, prediction of life-expectancy, communication about aging-related concerns, patient and family satisfaction with care, and outcomes when used to guide care. 3
- Use frailty assessment results to guide shared decision-making about goals of care, choice of interventions to prevent aging-related outcomes (such as falls and polypharmacy), and likelihood of receiving goal-concordant care. 3